| Zacks Company Profile for AngioDynamics, Inc. (ANGO : NSDQ) |
|
|
| |
| • Company Description |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines.
Number of Employees: 748 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $9.19 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 532,721 shares |
| Shares Outstanding: 40.61 (millions) |
| Market Capitalization: $373.18 (millions) |
| Beta: 0.60 |
| 52 Week High: $13.50 |
| 52 Week Low: $5.47 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-17.36% |
-20.33% |
| 12 Week |
-6.13% |
-18.55% |
| Year To Date |
0.33% |
-5.28% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
James C. Clemmer - President and Chief Executive Officer
Howard W. Donnelly - Chairman and Director
Stephen A. Trowbridge - Executive Vice President and Chief Financial Offic
Wesley E. Johnson, Jr. - Director
Jan S. Reed - Director
|
|
Peer Information
AngioDynamics, Inc. (ABMD)
AngioDynamics, Inc. (DMDS)
AngioDynamics, Inc. (CPWY.)
AngioDynamics, Inc. (EQUR)
AngioDynamics, Inc. (ECIA)
AngioDynamics, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 03475V101
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: May
Last Reported Quarter: 02/01/25
Next Expected EPS Date: 07/15/25
|
|
Share - Related Items
Shares Outstanding: 40.61
Most Recent Split Date: (:1)
Beta: 0.60
Market Capitalization: $373.18 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.12 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-0.24 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 3.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/15/25 |
|
|
|
| |
